Topical Therapy for Androgenetic Alopecia Clinical Trial
A Clinical trial by Pelage Pharmaceuticals announces positive results for a topical therapy for androgenetic alopecia. It is designed to reactivate dormant hair follicle stem cells
https://www.ncbi.nlm.nih.gov/m/pubmed/31823902/
This paper demonstrates the efficacy of combination therapy in treating male and female pattern hair loss.
The key is to be compliant with at least one therapy for success.
Combination therapy makes the success more likely for patients that can do two treatments at once.